327 related articles for article (PubMed ID: 19407253)
21. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
[TBL] [Abstract][Full Text] [Related]
22. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
23. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
Li PL; Jin MW; Campbell WB
Hypertension; 1998 Jan; 31(1 Pt 2):303-8. PubMed ID: 9453320
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig.
Kruuse C; Khurana TS; Rybalkin SD; Birk S; Engel U; Edvinsson L; Olesen J
Eur J Pharmacol; 2005 Oct; 521(1-3):105-14. PubMed ID: 16182282
[TBL] [Abstract][Full Text] [Related]
25. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
26. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonism.
Tseng KY; Caballero A; Dec A; Cass DK; Simak N; Sunu E; Park MJ; Blume SR; Sammut S; Park DJ; West AR
PLoS One; 2011; 6(11):e27187. PubMed ID: 22073284
[TBL] [Abstract][Full Text] [Related]
29. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
30. Chronic hypoxia attenuates the vasodilator efficacy of protein kinase G in fetal and adult ovine cerebral arteries.
Thorpe RB; Hubbell MC; Silpanisong J; Williams JM; Pearce WJ
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H207-H219. PubMed ID: 28550175
[TBL] [Abstract][Full Text] [Related]
31. NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel.
Dismuke WM; Mbadugha CC; Ellis DZ
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1378-86. PubMed ID: 18385281
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis.
Didion SP; Heistad DD; Faraci FM
Stroke; 2001 Mar; 32(3):761-6. PubMed ID: 11239199
[TBL] [Abstract][Full Text] [Related]
33. Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.
Neo BH; Kandhi S; Wolin MS
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2295-304. PubMed ID: 21926339
[TBL] [Abstract][Full Text] [Related]
34. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
[TBL] [Abstract][Full Text] [Related]
35. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one inhibits neurite outgrowth and causes neurite retraction in PC12 cells independently of soluble guanylyl cyclase.
Lee HG; Kim SY; Kim du S; Seo SR; Lee SI; Shin DM; De Smet P; Seo JT
J Neurosci Res; 2009 Jan; 87(1):269-77. PubMed ID: 18711750
[TBL] [Abstract][Full Text] [Related]
36. [Hypotensive effect of oxatriazolo-5-olate derivative in chronic experiments on SHR rats].
Artem'eva MM; Postnikov AB; Akinfieva OV; Daliger IL; Shevelev SA; Medvedev OS; Medvedeva NA
Eksp Klin Farmakol; 2009; 72(3):13-5. PubMed ID: 19642586
[TBL] [Abstract][Full Text] [Related]
37. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.
Ellis DZ; Dismuke WM; Chokshi BM
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1808-13. PubMed ID: 19074804
[TBL] [Abstract][Full Text] [Related]
38. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
[TBL] [Abstract][Full Text] [Related]
40. S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism.
Liu T; Schroeder HJ; Zhang M; Wilson SM; Terry MH; Longo LD; Power GG; Blood AB
Nitric Oxide; 2016 Aug; 58():20-7. PubMed ID: 27235767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
